[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2023-2027 Antinuclear Antibody (ANA) Screening Market in the USA and Canada—Supplier Sales and Shares; Volume and Sales Forecasts for Hospitals, Labs, POC Locations, Technologies and Methods; Instrumentation Review and Supplier Profiles

October 2023 | | ID: 26868EAD77A1EN
Venture Planning Group

US$ 1,960.00 US$ 2,450.00 -20 %
Offer valid until August 06, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from LeadingMarketResearch.com provides granular data and analysis not available from any other source.
Countries Analyzed in the Report

Canada
USA

Diagnostic Technologies and Methods

Immunofluorescence
Multiplexed Bead Immunoassay
Enzyme Immunoassay
Enzyme Linked Fluorescent Immunoassay
Chemiluminescence

Market Segments
Hospitals
Commercial/Private Laboratories
Physician Offices
POC/Other Locations

Supplier Sales and Market Shares
Aesku
Bio-Rad
DiaSorin
EUROIMMUN/PerkinElmer
Immuno Concepts
Inova/Werfen
Orgentec/Sebia
Phadia/Thermo Fisher
Thera Test

Instrumentation Review

The report reviews latest ANA analyzers from Bio-Rad, DiaSorin, EUROIMMUN, Inova and Phadia.

Competitive Assessments

The report provides strategic profiles of major suppliers.

Strategic Recommendations

Product development and business expansion opportunities with significant market appeal.
“Ideal” product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.



More Publications